GSK Acquires IDRx for $1B to Boost GIST Treatment Pipeline
CompanyDeals

GSK Acquires IDRx for $1B to Boost GIST Treatment Pipeline

Autobio Diagnostics Partners with Boditech Med for Korean IVD Market
CompanyDeals

Autobio Diagnostics Partners with Boditech Med for Korean IVD Market

Henlius and Abbott Sign License Agreement for Biosimilars and Biologic Drug
CompanyDeals

Henlius and Abbott Sign License Agreement for Biosimilars and Biologic Drug

Chongqing Genrix's Silevimig NDA Accepted for Rabies Immunization Review
CompanyDrug

Chongqing Genrix’s Silevimig NDA Accepted for Rabies Immunization Review

Novartis to Defend Entresto Patent After CAFC Ruling
Legal / IP

Novartis to Defend Entresto Patent After CAFC Ruling

Bristol-Myers Squibb Exercises License for ArsenalBio's AB-4000 Series
CompanyDeals

Bristol-Myers Squibb Exercises License for ArsenalBio’s AB-4000 Series

Hengrui and Kailera Announce Positive Phase II Results for HRS9531 in Weight Loss
CompanyDrug

Hengrui and Kailera Announce Positive Phase II Results for HRS9531 in Weight Loss

Gentize Biopharma Raises $13.64M in Pre-Series A for Vaccine Development
CompanyDeals

Gentize Biopharma Raises $13.64M in Pre-Series A for Vaccine Development

Roche's VENTANA Kappa and Lambda Dual ISH Test Gains FDA Clearance
CompanyMedical Device

Roche’s VENTANA Kappa and Lambda Dual ISH Test Gains FDA Clearance

Illumina Partners with NVIDIA to Advance Multiomic Data Analysis
CompanyDeals

Illumina Partners with NVIDIA to Advance Multiomic Data Analysis

Leqembi Autoinjector Advances with FDA Review for Alzheimer's Treatment
CompanyDrug

Leqembi Autoinjector Advances with FDA Review for Alzheimer’s Treatment

Mediar Therapeutics and Eli Lilly Ink Deal for IPF Drug MTX-463
CompanyDeals

Mediar Therapeutics and Eli Lilly Ink Deal for IPF Drug MTX-463